IHO1
gene geneOn this page
Also known as FLJ25320CT74LELA1
Summary
IHO1 (interactor of HORMAD1 1, HGNC:27945) is a protein-coding gene on chromosome 3p21.31, encoding Interactor of HORMAD1 protein 1 (Q8IYA8). Required for DNA double-strand breaks (DSBs) formation in unsynapsed regions during meiotic recombination.
Predicted to be involved in several processes, including meiosis I cell cycle process; regulation of homologous chromosome segregation; and spermatogenesis. Predicted to be located in chromosome. Predicted to be active in condensed nuclear chromosome.
Source: NCBI Gene 339834 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 80 total
- MANE Select transcript:
NM_001135197
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27945 |
| Approved symbol | IHO1 |
| Name | interactor of HORMAD1 1 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25320, CT74, LELA1 |
| Ensembl gene | ENSG00000173421 |
| Ensembl biotype | protein_coding |
| OMIM | 619190 |
| Entrez | 339834 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000296449, ENST00000366429, ENST00000438782, ENST00000452691, ENST00000493870, ENST00000909984, ENST00000961111
RefSeq mRNA: 2 — MANE Select: NM_001135197
NM_001135197, NM_178173
CCDS: CCDS33755
Canonical transcript exons
ENST00000452691 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001080962 | 49241226 | 49241389 |
| ENSE00001080965 | 49244404 | 49244452 |
| ENSE00001204715 | 49244646 | 49244733 |
| ENSE00001204734 | 49255390 | 49255493 |
| ENSE00001335195 | 49236548 | 49236722 |
| ENSE00001498333 | 49211766 | 49211836 |
| ENSE00001643409 | 49199498 | 49199573 |
| ENSE00003851164 | 49256134 | 49258106 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 91.65.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8151 / max 86.1572, expressed in 631 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36617 | 1.2045 | 546 |
| 36618 | 0.6106 | 299 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 91.65 | gold quality |
| right testis | UBERON:0004534 | 90.92 | gold quality |
| testis | UBERON:0000473 | 88.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.37 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.70 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.02 | gold quality |
| buccal mucosa cell | CL:0002336 | 72.90 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 72.34 | gold quality |
| left ovary | UBERON:0002119 | 71.20 | gold quality |
| sperm | CL:0000019 | 70.78 | gold quality |
| endothelial cell | CL:0000115 | 70.71 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 70.07 | gold quality |
| right ovary | UBERON:0002118 | 69.37 | gold quality |
| apex of heart | UBERON:0002098 | 69.19 | gold quality |
| ovary | UBERON:0000992 | 68.68 | gold quality |
| adrenal tissue | UBERON:0018303 | 67.62 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 66.98 | gold quality |
| adult organism | UBERON:0007023 | 65.56 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 65.55 | gold quality |
| right adrenal gland | UBERON:0001233 | 65.10 | gold quality |
| left adrenal gland | UBERON:0001234 | 64.75 | gold quality |
| tendon | UBERON:0000043 | 64.52 | gold quality |
| adrenal gland | UBERON:0002369 | 64.16 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 64.13 | gold quality |
| omental fat pad | UBERON:0010414 | 63.93 | gold quality |
| peritoneum | UBERON:0002358 | 63.87 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 63.53 | gold quality |
| lower esophagus | UBERON:0013473 | 63.50 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 63.35 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 63.22 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.57 |
| E-MTAB-7606 | no | 2.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting IHO1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-1912-3P | 99.32 | 67.40 | 936 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc36 | ENSDARG00000097704 |
| mus_musculus | Iho1 | ENSMUSG00000047220 |
| rattus_norvegicus | Iho1 | ENSRNOG00000048919 |
Protein
Protein identifiers
Interactor of HORMAD1 protein 1 — Q8IYA8 (reviewed: Q8IYA8)
Alternative names: Cancer/testis antigen 74, Coiled-coil domain-containing protein 36
All UniProt accessions (1): Q8IYA8
UniProt curated annotations — full annotation on UniProt →
Function. Required for DNA double-strand breaks (DSBs) formation in unsynapsed regions during meiotic recombination. Probably acts by forming a complex with MEI4 and REC114, which activates DSBs formation in unsynapsed regions, an essential step to ensure completion of synapsis. Not required for HORMAD1 functions in pairing-independent synaptonemal complex formation, ATR recruitment to unsynapsed axes, meiotic silencing of unsynapsed chromatin (MSUC) or meiotic surveillance.
Subunit / interactions. Part of the MCD recombinosome complex, at least composed of IHO1, REC114 and MEI4. Interacts with REC114. Interacts with MEI4. Interacts with HORMAD1. Interacts with ANKRD31.
Subcellular location. Chromosome.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IYA8-1 | 1 | yes |
| Q8IYA8-2 | 2 | |
| Q8IYA8-3 | 3 |
RefSeq proteins (2): NP_001128669, NP_835467 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031529 | IHO1 | Family |
Pfam: PF15771
UniProt features (14 total): splice variant 4, coiled-coil region 3, compositionally biased region 2, modified residue 2, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYA8-F1 | 55.17 | 0.22 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 588, 589
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 48 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, GOBP_FEMALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CELL_CYCLE_PROCESS
GO Biological Process (8): DNA recombination (GO:0006310), homologous chromosome pairing at meiosis (GO:0007129), spermatogenesis (GO:0007283), meiotic DNA double-strand break formation (GO:0042138), oogenesis (GO:0048477), regulation of homologous chromosome segregation (GO:0060629), cell differentiation (GO:0030154), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): condensed nuclear chromosome (GO:0000794), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA metabolic process | 2 |
| homologous chromosome segregation | 2 |
| chromosome organization involved in meiotic cell cycle | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| meiosis I cell cycle process | 1 |
| germ cell development | 1 |
| female gamete generation | 1 |
| regulation of chromosome segregation | 1 |
| regulation of reproductive process | 1 |
| cellular developmental process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| nuclear chromosome | 1 |
| condensed chromosome | 1 |
| nucleus | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
562 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IHO1 | REC114 | Q7Z4M0 | 953 |
| IHO1 | HORMAD1 | Q86X24 | 949 |
| IHO1 | MEI4 | A8MW99 | 913 |
| IHO1 | CXXC1 | Q9P0U4 | 904 |
| IHO1 | ANKRD31 | Q8N7Z5 | 870 |
| IHO1 | MEI1 | Q5TIA1 | 805 |
| IHO1 | SPO11 | Q9Y5K1 | 802 |
| IHO1 | TOP6BL | Q8N6T0 | 800 |
| IHO1 | PRDM9 | Q9NQV7 | 778 |
| IHO1 | CD151 | P48509 | 672 |
| IHO1 | PRR35 | P0CG20 | 592 |
| IHO1 | SYCP1 | Q15431 | 571 |
| IHO1 | SYCP3 | Q8IZU3 | 570 |
| IHO1 | HORMAD2 | Q8N7B1 | 548 |
| IHO1 | RAD21L1 | Q9H4I0 | 545 |
IntAct
324 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FKBP6 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| IHO1 | FKBP6 | psi-mi:“MI:0915”(physical association) | 0.830 |
| IHO1 | PRKAB2 | psi-mi:“MI:0915”(physical association) | 0.760 |
| PRKAB2 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.760 |
| IHO1 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ABI2 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| GYS1 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| DYNLL1 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LONRF1 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | KANK2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TTC19 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NGB | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| AIRIM | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | CDC23 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | USP20 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | GYS1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | DYNLL1 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (118): CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid), CCDC36 (Two-hybrid)
ESM2 similar proteins: A2A7Y5, A2AFS9, A2AIW0, A6NFA0, A6NMK8, A9JRX0, B2RQL2, C3VD30, P54257, Q0VET5, Q0VG85, Q14B48, Q2M243, Q2YDE2, Q3V036, Q3V0C3, Q3V0M2, Q4R739, Q5E9L4, Q5PQS2, Q5R9L2, Q60664, Q6AYH0, Q6AYP4, Q6DF94, Q6GQV1, Q6NZK5, Q6P1D7, Q6ZRS4, Q6ZVD7, Q70YC5, Q7L3B6, Q7M6U3, Q7Z572, Q86WZ0, Q8BG89, Q8CCC3, Q8CCG1, Q8CH09, Q8IYA8
Diamond homologs: Q6PDM4, Q8IYA8
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | IHO1 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1468 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:49236719:GGAG:G | donor_gain | 1.0000 |
| 3:49236720:GAGG:G | donor_gain | 1.0000 |
| 3:49236721:AGGT:A | donor_loss | 1.0000 |
| 3:49236723:GTGA:G | donor_loss | 1.0000 |
| 3:49236724:T:A | donor_loss | 1.0000 |
| 3:49241217:A:AG | acceptor_gain | 1.0000 |
| 3:49241221:AACAG:A | acceptor_gain | 1.0000 |
| 3:49241222:A:G | acceptor_gain | 1.0000 |
| 3:49241222:ACAG:A | acceptor_gain | 1.0000 |
| 3:49241224:A:AG | acceptor_gain | 1.0000 |
| 3:49241224:A:AT | acceptor_loss | 1.0000 |
| 3:49241224:AG:A | acceptor_gain | 1.0000 |
| 3:49241224:AGG:A | acceptor_gain | 1.0000 |
| 3:49241224:AGGGT:A | acceptor_gain | 1.0000 |
| 3:49241225:G:GA | acceptor_gain | 1.0000 |
| 3:49241225:GG:G | acceptor_gain | 1.0000 |
| 3:49241225:GGG:G | acceptor_gain | 1.0000 |
| 3:49241225:GGGT:G | acceptor_gain | 1.0000 |
| 3:49241225:GGGTG:G | acceptor_gain | 1.0000 |
| 3:49241385:GACAG:G | donor_gain | 1.0000 |
| 3:49241386:ACAG:A | donor_gain | 1.0000 |
| 3:49244645:G:GT | acceptor_gain | 1.0000 |
| 3:49244729:GACAT:G | donor_gain | 1.0000 |
| 3:49244734:G:GG | donor_gain | 1.0000 |
| 3:49255388:A:AG | acceptor_gain | 1.0000 |
| 3:49255389:G:GG | acceptor_gain | 1.0000 |
| 3:49255389:GTACA:G | acceptor_gain | 1.0000 |
| 3:49255491:GCT:G | donor_gain | 1.0000 |
| 3:49255492:CT:C | donor_gain | 1.0000 |
| 3:49255492:CTGT:C | donor_loss | 1.0000 |
AlphaMissense
3952 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:49236618:T:C | F43L | 0.967 |
| 3:49236620:T:A | F43L | 0.967 |
| 3:49236620:T:G | F43L | 0.967 |
| 3:49236630:T:C | F47L | 0.967 |
| 3:49236632:C:A | F47L | 0.967 |
| 3:49236632:C:G | F47L | 0.967 |
| 3:49241349:T:C | F119L | 0.964 |
| 3:49241351:T:A | F119L | 0.964 |
| 3:49241351:T:G | F119L | 0.964 |
| 3:49236612:T:C | F41L | 0.962 |
| 3:49236614:C:A | F41L | 0.962 |
| 3:49236614:C:G | F41L | 0.962 |
| 3:49211796:T:A | W6R | 0.960 |
| 3:49211796:T:C | W6R | 0.960 |
| 3:49257175:T:C | F560L | 0.955 |
| 3:49257177:C:A | F560L | 0.955 |
| 3:49257177:C:G | F560L | 0.955 |
| 3:49236622:G:A | G44E | 0.952 |
| 3:49236600:A:C | S37R | 0.948 |
| 3:49236602:T:A | S37R | 0.948 |
| 3:49236602:T:G | S37R | 0.948 |
| 3:49236613:T:C | F41S | 0.948 |
| 3:49244691:A:C | S164R | 0.948 |
| 3:49244693:C:A | S164R | 0.948 |
| 3:49244693:C:G | S164R | 0.948 |
| 3:49241250:T:G | Y86D | 0.946 |
| 3:49257259:A:C | S588R | 0.946 |
| 3:49257261:C:A | S588R | 0.946 |
| 3:49257261:C:G | S588R | 0.946 |
| 3:49256168:T:C | L224P | 0.941 |
dbSNP variants (sampled 300 via entrez): RS1000045735 (3:49254370 G>A), RS1000089295 (3:49226239 A>G,T), RS1000143530 (3:49239152 A>G), RS1000196326 (3:49223309 C>T), RS1000201112 (3:49226202 C>T), RS1000242397 (3:49220327 G>A), RS1000317814 (3:49220145 G>A), RS1000343409 (3:49202388 C>T), RS1000355289 (3:49235130 G>A), RS1000525689 (3:49221927 G>A), RS1000536983 (3:49244501 A>G), RS1000745799 (3:49237639 A>G), RS1000847572 (3:49213654 C>G,T), RS1000871693 (3:49231103 T>C,G), RS1000900397 (3:49194802 G>A)
Disease associations
OMIM: gene MIM:619190 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_23 | Inflammatory bowel disease | 1.000000e-33 |
| GCST004132_17 | Crohn’s disease | 3.000000e-23 |
| GCST004133_11 | Ulcerative colitis | 8.000000e-20 |
| GCST004602_128 | Mean corpuscular volume | 1.000000e-11 |
| GCST004630_116 | Mean corpuscular hemoglobin | 8.000000e-12 |
| GCST008163_589 | Height | 3.000000e-06 |
| GCST008357_20 | Mood instability | 4.000000e-11 |
| GCST008526_26 | Coffee consumption | 2.000000e-06 |
| GCST010698_80 | Subcortical volume (min-P) | 3.000000e-24 |
| GCST010699_110 | Brain morphology (min-P) | 4.000000e-08 |
| GCST010701_52 | Cortical surface area (MOSTest) | 1.000000e-16 |
| GCST010702_36 | Subcortical volume (MOSTest) | 1.000000e-10 |
| GCST010703_262 | Brain morphology (MOSTest) | 2.000000e-13 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0008475 | mood instability measurement |
| EFO:0006781 | coffee consumption measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Silicon Dioxide | increases expression | 2 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| bromovanin | decreases expression | 1 |
| bisphenol S | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Testosterone | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.